CBOE vs LFCR · P/E 24, rev $2.72B vs rev $75.5M
Cboe Global Markets Inc (CBOE) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the CBOE and LFCR stock pages for the full models.
Not investment advice.